Page 9 - Michael Schneiders News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael schneiders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Schneiders Today - Breaking & Trending Today

BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd.


BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd.
DGAP-News: BRAIN Biotech AG
/ Key word(s): Investment
12.05.2021 / 16:30
Zwingenberg, Germany, May 12, 2021
BRAIN Biotech AG expands stake in successful enzyme producer Biocatalysts Ltd.
BRAIN has acquired additional shares in Biocatalysts Ltd.
Biocatalysts strong business trend
Planned additional capacity expansion now targeted earlier
BRAIN Biotech AG has expanded its shareholdings in the successful enzyme producer Biocatalysts Ltd., Wales, to 82.2% by the purchase of additional shares from minority shareholders. Due to the strong business performance at Biocatalysts Ltd. current production capacity will be fully utilised although only coming on stream in early 2021. The 2nd phase of expansion is planned to be accelerated as a result. ....

United Kingdom , Lukas Linnig , Adriaan Moelker , Michael Schneiders , Stephanie Konle , Biocatalysts Ltd , Pr Corporate Communications , Md Biocatalysts Ltd , Standard Of The Frankfurt Stock Exchange , Sears Black , Prime Standard , Frankfurt Stock Exchange , Investor Relations , ஒன்றுபட்டது கிஂக்டம் , மைக்கேல் ஸ்க்னீடர்ஸ் , ப்ர் பெருநிறுவன தகவல்தொடர்புகள் , தரநிலை ஆஃப் தி பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , ப்ரைம் தரநிலை , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , முதலீட்டாளர் உறவுகள் ,

Investegate |BRAIN Biotech AG Announcements | BRAIN Biotech AG: Genome Editing Tool Developed by BRAIN


- Different commercialization models currently being explored
BRAIN Biotech AG has successfully completed the first development phase for a novel genome editing CRISPR Cas system applying its advanced metagenomics sequencing and protein engineering capabilities. BRAIN s technology enabled by a novel and independent
Non-CAS9-Nuclease will significantly speed up in-house developments and promises significant economic upside.
Genome editing has lately become one of the most exciting technologies in biotechnology. It allows for the directed and precise insertion, deletion or modification in the genome of a living organism. The CRISPR-CAS system has provided a genetic tool with speed as well as simplicity that was previously unavailable to science. ....

United Kingdom , Michael Krohn , Lukas Linnig , Adriaan Moelker , Michael Schneiders , Stephanie Konle , Pr Corporate Communications , Standard Of The Frankfurt Stock Exchange , Editing Tool Developed , Prime Standard , Frankfurt Stock Exchange , Investor Relations , ஒன்றுபட்டது கிஂக்டம் , மைக்கேல் க்ரோன் , மைக்கேல் ஸ்க்னீடர்ஸ் , ப்ர் பெருநிறுவன தகவல்தொடர்புகள் , தரநிலை ஆஃப் தி பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , ப்ரைம் தரநிலை , பிராங்க்ஃபர்ட் ஸ்டாக் பரிமாற்றம் , முதலீட்டாளர் உறவுகள் ,